| [1] |
Laird PW. Cancer epigenetics[J]. Hum Mol Genet, 2005, 14 Spec No 1: R65-76.
|
| [2] |
Kim YH, Lee HC, Kim SY, et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations[J]. Ann Surg Oncol, 20 11, 18(8): 2338-47.
|
| [3] |
Shah AK, Saunders NA, Barbour AP, et al. Early diagnostic biomarkers for esophageal adenocarcinoma--the current state of play[J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(7): 11 85-209.
|
| [4] |
Jjingo D, Conley AB, Yi SV, et al. On the presence and role of human gene-body DNA methylation[J]. Oncotarget, 2012, 3(4): 46 2-74.
|
| [5] |
Doi A, Park IH, Wen B, et al. Differential methylation of tissueand cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts[J]. Nat Genet, 2009, 41(12): 1350-3.
|
| [6] |
Ji H, Ehrlich LI, Seita J, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors[J]. Nature, 20 10, 467(7313): 338-42.
|
| [7] |
Okano T, Gemma A, Hosoya Y, et al. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer[J]. Oncol Rep, 2006, 15(3): 545-9.
|
| [8] |
Borkosky SS, Gunduz M, Nagatsuka H, et al. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma[J]. J Cancer Res Clin Oncol, 2009, 135(5): 703-13.
|
| [9] |
Lu F, Dai DL, Martinka M, et al. Nuclear ING2 expression is reduced in human cutaneous melanomas[J]. Br J Cancer, 2006, 95 (1): 80-6.
|
| [10] |
Chen IF, Ou-Yang F, Hung JY, et al. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model[J]. Mol Cancer Ther, 2006, 5(1): 1-7.
|
| [11] |
Jin Z, Cheng Y, Olaru A, et al. Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors[J]. Int J Cancer, 2008, 123(10): 2331-6.
|
| [12] |
Cho YG, Kim CJ, Park CH, et al. Genetic alterations of the KLF6 gene in gastric cancer[J]. Oncogene, 2005, 24(28): 4588-90.
|
| [13] |
Narla G, Heath KE, Reeves HL, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer[J]. Science, 2001, 29 4(5551): 2563-6.
|
| [14] |
Reeves HL, Narla G, Ogunbiyi O, et al. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer[J]. Gastroenterology, 2004, 126(4): 1090-103.
|
| [15] |
Spinola M, Galvan A, Pignatiello C, et al. Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer[J]. Oncogene, 2005, 24(35): 5502-9.
|
| [16] |
Lin K, Taylor JR Jr, Wu TD, et al. TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma[J]. PLoS One, 2011, 6(4): e18608.
|
| [17] |
Tsunoda S, Smith E, De Young NJ, et al. Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma[J]. Oncol Rep, 2009, 21(4): 1067-73.
|
| [18] |
Liu Z, Yang X, Li Z, et al. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression[J]. Cell Death Differ, 2011, 18 (7): 1174-83.
|
| [19] |
Lung HL, Lo PH, Xie D, et al. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma[J]. Int J Cancer, 2008, 123(2): 401-8.
|
| [20] |
Zhang C, Shao Y, Zhang W, et al. High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal, and pancreatic cancers[J]. Cancer Genet Cytogenet, 2010, 196(1): 38 -44.
|
| [21] |
Lo PH, Lung HL, Cheung AK, et al. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis[J]. Cancer Res, 2010, 70 (13): 5567-76.
|
| [22] |
Zhao LY, Niu Y, Santiago A, et al. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis[J]. Cancer Res, 2006, 66(19): 9445-52.
|
| [23] |
Jin SH, Akiyama Y, Fukamachi H, et al. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells[J]. Int J Cancer, 2008, 122(5): 1040-6.
|
| [24] |
White CD, Khurana H, Gnatenko DV, et al. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma[J]. BMC Gastroenterol, 2010, 10: 125.
|
| [25] |
Xie Y, Yan J, Cutz JC, et al. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis[J]. Biochim Biophys Acta, 20 12, 1822(6): 875-84.
|
下载:
